Press Releases


February 23, 2021

AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials

January 12, 2021

Notal Vision Launches First U.S. Home OCT Longitudinal Study with Patient Self-operated Device

August 25, 2020

AI-based OCT analysis of AREDS2 10-Y follow-on study demonstrates superior performance over retina specialists

July 28, 2020

ForeseeHome AMD home monitoring real-world data analysis compares favorably to HOME study

June 17, 2020

Home OCT longitudinal home-based study with patient self-operated device has begun

Media enquiries? Reach out to our Media Contact